Vanda Pharmaceuticals: Soaring On Bysanti Approval, But You Shouldn't Feel Dizzy (VNDA)

Vanda Pharmaceuticals Inc. is rated a Buy due to potential upside from new launches and pipeline catalysts. Learn more about VNDA stock here.

You will be redirected in 10 seconds.

liveinternet liveinternet